Baylor Genetics to Highlight Genetic Testing Use Cases and Advancements in Rare Disease at The National Society of Genetic Counselors 44th Annual Conference
HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic…
Xinhua Silk Road: Annual Conference of Financial Street Forum 2025 concludes with fruitful results
BEIJING, Nov. 3, 2025 /PRNewswire/ -- The Annual Conference of Financial Street…
Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (āFangzhouā or…
Edesa Biotech Announces Upcoming Conference Schedule
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a…
AMSC to Report Second Quarter Fiscal Year 2025 Financial Results on November 5, 2025
October 31, 2025 16:33 ET Ā | Source: AMSC AYER, Mass., Oct. 31,…
CORRECTION Micron Announces Participation in Investor Event
BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued…
authID to Report Third Quarter 2025 Financial Results on November 12, 2025
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- authIDĀ® (Nasdaq: AUID) (āauthIDā or…
Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular…
Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3KĪ± and strongly inhibits pAKT…